Ford Motor Co. will produce 50,000 ventilators over a 100-day period at a plant in Michigan in cooperation with General Electric’s healthcare unit, and can then build 30,000 per month as needed to treat patients afflicted with the coronavirus.
Sanofi and Regeneron Pharmaceuticals expanded a clinical trial of the companies’ rheumatoid arthritis drug Kevzara as a coronavirus treatment to patients outside the United States.
The number of U.S. coronavirus infections climbed above 86,000 on Friday as New York, New Orleans and other hot spots faced a surge in hospitalizations and looming shortages of supplies, staff and sick beds.
Italian researchers are looking at whether a higher than usual number of cases of severe pneumonia and flu in Lombardy in the last quarter of 2019 may be a signal that the new coronavirus might have spread beyond China earlier than previously thought.
In response to calls for personal protective equipment for health care workers and other front-line responders battling the COVID-19 pandemic, Merck & Co. Inc. is donating 300,000 masks to New Jersey’s Office of Homeland Security and Preparedness. Merck already donated 500,000 masks for use in New York City.
Sales of Bristol-Myers Squibb Co.’s cancer drug Abraxane were suspended in China based on findings at a third-party manufacturing plant in the United States.
The Indian government banned the export of hydroxychloroquine and formulations made from the medication, as experts test the efficacy of the drug in helping treat patients infected with COVID-19.
Join Ipsos for an interactive, complimentary “Ask us anything” webinar examining how public mood is changing as a result of Covid-19, where concerns are most focused now, and how the crisis is affecting American’s behavior now and in the future.
As a critical industry during the COVID-19 pandemic, biopharma companies are expected to remain in operation – but with a skeleton staff. Anticipating stay-at-home mandates, life sciences companies and labs in especially hard-hit regions had already begun preparing.
As the world tries to limit the spread of the novel coronavirus that causes COVID-19, there is some hope that warmer weather will cause the virus to dwindle, like what happens with seasonal influenza. Though research indicates that COVID-19 could be seasonal, returning in the fall.